
MI-503
CAS No. 1857417-13-0
MI-503( MI 503 | MI503 )
Catalog No. M12868 CAS No. 1857417-13-0
A highly potent and orally bioavailable small-molecule inhibitor of Menin-MLL interaction with Kd of 9.3 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 105 | Get Quote |
![]() ![]() |
5MG | 197 | Get Quote |
![]() ![]() |
10MG | 329 | Get Quote |
![]() ![]() |
25MG | 493 | Get Quote |
![]() ![]() |
50MG | 710 | Get Quote |
![]() ![]() |
100MG | 981 | Get Quote |
![]() ![]() |
200MG | 1332 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMI-503
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent and orally bioavailable small-molecule inhibitor of Menin-MLL interaction with Kd of 9.3 nM.
-
DescriptionA highly potent and orally bioavailable small-molecule inhibitor of Menin-MLL interaction with Kd of 9.3 nM; effectively induces differentiation of MLL leukemia cells and and substantially increases expression of CD11b, also reduces expression of Hoxa9 and Meis1; induces marked anti-proliferative effects in MV4;11 cells with GI50 of 200 nM; blocks hematologic tumors in vivo and reduces MLL leukemia tumor burden in mouse models.Blood Cancer Preclinical.
-
In Vitro——
-
In Vivo——
-
SynonymsMI 503 | MI503
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1857417-13-0
-
Formula Weight564.6278
-
Molecular FormulaC28H27F3N8S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESN#CC(N1CC2=CNN=C2)=CC3=C1C=CC(CN4CCC(NC5=C(C=C(CC(F)(F)F)S6)C6=NC=N5)CC4)=C3C
-
Chemical Name1-((1H-pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Borkin D, et al. Cancer Cell. 2015 Apr 13;27(4):589-602.
2. Svoboda LK, et al. Oncotarget. 2017 Jan 3;8(1):458-471.
molnova catalog



related products
-
MI-538
MI-538 is potent and selective menin–MLL interaction inhibitor (IC50=21 nM).
-
T1551
T1551 is a novel, potent and specific PRMT5 inhibitor with IC50 of 34.1 uM.
-
PR5-LL-CM01
PR5-LL-CM01 is a novel selective, small-molecule inhibitor of PRMT5 methyltransferase with IC50 of 7.5 uM.